Close This website uses modern features that are not supported by your browser. Click here for more information.
Please upgrade to a modern browser to view this website properly. Google Chrome Mozilla Firefox Opera Safari
your legal news hub
Sub Menu
Search

Search

Filter
Filter
Filter
A A A

Rwanda recalls Indian medication

Publish date: 16 May 2022
Issue Number: 976
Diary: IBA Legalbrief Africa
Category: Health

The Rwanda Food and Drugs Authority (RFDA) has recalled India-manufactured batches of Amoxicillin 125mg/5ml Oral Suspension and Metronidazole vaginal 500mg due to quality issues. News24 notes that this followed ‘a deep investigation and laboratory quality control tests’. The medicines, which had expiry dates ranging between 2023 and 2024, were produced by Sparsh biotech and Agog Pharma Ltd. ‘All importers, central medical stores, wholesalers, district pharmacies, retailers, public and private health facilities to stop the distribution of the recalled medicines and return them to the suppliers for suitable management,’ said RFDA director-general Dr Emile Bienvenu.

Full Fin24 report

We use cookies to give you a personalised experience that suits your online behaviour on our websites. Otherwise, you may click here to learn more, or learn how to block or disable cookies. Disabling cookies might cause you to experience difficulties on our website as some functionality relies on cookie information. You can change your mind at any time by visiting “Cookie Preferences”. Any personal data about you will be used as described in our Privacy Policy.